careviso’s proprietary AI-Powered Automation Drives over 1600 Products Supported with 87% Benefit Pullback Rate and 20-Second Average Turnaround Time During Peak SeasonVIENNA, Va., March 6, 2026 /PRNewswire/ — careviso, a leader in automation-enabled patient access, today announced the successful completion of the 2026 Annual Reverification (AR) season, alongside the launch of a powerful new seeQer capability, Prior Authorization (PA) on File intelligence enabling teams to instantly determine whether a prior authorization already exists for a patient.Together, these milestones underscore careviso’s continued investment in automation, structured intelligence, and scalable infrastructure designed to modernize patient access operations.Amid a 185% increase in reverification volume compared to the previous year, careviso delivered real-time results, expanded data capabilities, and industry-leading turnaround times to support patients, providers, and life sciences partners during one of the most demanding times of the year.During AR season 2026, seeQer supported 1672 unique products across 51 distinct clients, achieving an 87% benefit pullback rate with an average turnaround time (TAT) of just 20 seconds. At peak volume, the platform processed a single-day high of 10,931 patients, demonstrating its ability to scale rapidly while maintaining accuracy and performance. During the months of January and February, seeQer processed over 330,000 distinct cases.To prepare for the significant increase in volume, careviso worked closely with existing programs to strengthen operational readiness and performance. These initiatives included:
- Increasing seeQer accuracy rates by proactively addressing common errors
- Delivering extensive portal training to seeQer users
- Building greater confidence in results through case studies and regular performance reporting

Source link











Leave a Reply